MADISON DALLMAN: Open Payments
NPI 1881431351 · QUEEN CREEK, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,748 in 96 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $453 · 2025 $1,748
Food & beverage: $1,748
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $399 |
| Novo Nordisk Inc | 15 | $274 |
| AstraZeneca Pharmaceuticals LP | 3 | $249 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $199 |
| PFIZER INC. | 14 | $153 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| Lilly USA, LLC | 4 | $71 |
| Astellas Pharma US Inc | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| TOLMAR, INC. | 3 | $50 |
Products named: BREZTRI, QULIPTA, CAPLYTA, Ozempic, VRAYLAR, Wegovy, NURTEC ODT, TRELEGY ELLIPTA.
Industry payments across AZ — which companies pay providers there.
